[The experience with the supervision and treatment of the patients presenting with external otitis].
This clinical study was designed to estimate the efficacy and tolerability of the locally applied Pimafucort preparation for the treatment of diffuse otitis of bacterial and mycotic origin. The results of dynamic bacteriological investigation in conjunction with clinical observations give reason to recommend the local therapy as the sole treatment of uncomplicated forms of diffuse external otitis.
V T
VT
Pal'chun
D S
DS
Ogorodnikov
D000287:Administration, Topical; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000188:drug therapy*; D010866:Natamycin / Q000627:therapeutic use*; D009355:Neomycin / Q000627:therapeutic use*; D010032:Otitis Externa / Q000188:drug therapy*; D055815:Young Adult
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D004338:Drug Combinations; C026675:pimafucort; D010866:Natamycin; D009355:Neomycin; D006854:Hydrocortisone